Elevated expression of DPD in tumor cells is known to confer 5-FU resistance (Jiang et al., 1997; Kikuchi et al., 2015), and upregulation of hepatic DPD expression has been shown to reduce drug exposures and promote the development of 5-FU–resistant tumors (Li et al., 2013). Here, DPYD is linked to neoplasm.